By around one year, some people may be close to 25% weight loss, with Phase 3 data showing up to 28.7% by week 68
signs of low blood sugar - dizziness, shakiness, confusion, sweating, rapid heartbeat - particularly if combining GLP-1 therapy with insulin or sulfonylurea diabetes medications
Days 4 to 7: Resume normal eating patterns (small, frequent, low-fat)
Pesquisas da Universidade de Copenhague mostraram que alguns nutrientes estimulam essa produo de maneira natural, sem necessidade de medicamentos
A note on GLP-1 agonists for weight loss Though GLP-1 agonists can be beneficial for weight loss, its important to keep in mind that there is limited research on the long-term effects of these medications
Document weekly dose, date, and injection sites to maintain consistency